Circulating levels of APN are reduced in obesity, T2D or periodontitis [8]–[11], whereas improvement in hyperglycemia of T2D upon treatment with thiazolidinediones [12], [13] or periodontal therapeutic intervention that decreased inflammation, significantly led to increased serum APN levels [14]. This evidence concerns the gene ANPEP and obesity disorder.